LLY
Eli Lilly and Company
Stock
$1,184.78+1.32 (+0.11%)Close Sep 28, 2026
| Long-term debt (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $47.9B | +40.0% | 19.8% | 17.8% |
| Long-term debt (Q2 2026) | $47.9B |
|---|---|
| YoY | +40.0% |
| 5-year CAGR | 19.8% |
| 10-year CAGR | 17.8% |
Long-term debt
| Period | Long-term debt | YoY |
|---|---|---|
| 2025 | $40.9B | +43.3% |
| 2024 | $28.5B | +55.7% |
| 2023 | $18.3B | +24.3% |
| 2022 | $14.7B | −4.0% |
| 2021 | $15.3B | −7.5% |
| 2020 | $16.6B | +20.0% |
| 2019 | $13.8B | +50.3% |
| 2018 | $9.2B | −7.5% |
| 2017 | $9.9B | +18.8% |
| 2016 | $8.4B | +5.0% |
| 2015 | $8.0B | +49.5% |
| 2014 | $5.3B | +27.0% |
| 2013 | $4.2B | −23.9% |
| 2012 | $5.5B | +1.0% |
| 2011 | $5.5B | −19.3% |
| 2010 | $6.8B | +2.0% |
| 2009 | $6.6B | +43.7% |
| 2008 | $4.6B | — |